Cost-effectiveness of patient observation on cranial CT use with minor head trauma.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
08 2022
Historique:
received: 10 12 2021
accepted: 04 02 2022
pubmed: 24 2 2022
medline: 22 7 2022
entrez: 23 2 2022
Statut: ppublish

Résumé

To evaluate the cost-effectiveness of planned observation on cranial CT use in children with minor head trauma. Planned secondary analysis of a multicentre prospective observation study. Australia and New Zealand. An analytic cohort of 18 471 children aged <18 years with Glasgow Coma Scale scores 14-15 presenting <24 hours after blunt head trauma stratified by the Pediatric Emergency Care Applied Research Network (PECARN) traumatic brain injury (TBI) risk categories. A plan for observation and immediate CT scan were documented after the initial assessment. The planned observation group included those with planned observation and no immediate plan for CT. Taking an Australian public-funded healthcare perspective, we estimated the cost-effectiveness of planned observation on the adjusted mean costs per child and CT use reduction by net benefit regression analysis using ordinary least squares with robust SEs and bootstrapping. All costs presented in 2018 euros. Planned observation in 4945 (27%) children was cost-saving of €85 (95% CI -120 to -51) with 10.4% lower CT use (95% CI 9.6 to 11.2). This strategy was cost-saving for the PECARN high-risk (-€757 (95% CI -961 to -554)) and intermediate-risk (-€52 (95% CI -99 to -4.3)) categories, with 43% (95% CI 39 to 47) and 11% (95% CI 9.6 to 12.4) lower CT use, respectively. The very low-risk category incurred more cost of €86 (95% CI 67 to 104) with planned observation and 0.05% lower CT use (95% CI -0.61 to 0.71). Planned ED observation in selected children with minor head trauma is cost-effective for reducing CT use for the PECARN intermediate-risk and high-risk categories. ACTRN12614000463673.

Identifiants

pubmed: 35193874
pii: archdischild-2021-323701
doi: 10.1136/archdischild-2021-323701
doi:

Banques de données

ANZCTR
['ACTRN12614000463673']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

712-718

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sonia Singh (S)

Department of Paediatrics, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia singhsd@student.unimelb.edu.au.
Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento, California, USA.

Stephen Hearps (S)

Child Neuropsychology, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Daniel K Nishijima (DK)

Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento, California, USA.

John Alexander Cheek (JA)

Department of Paediatrics, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.
Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Emergency Department, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Meredith Borland (M)

Emergency Medicine, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Divisions of Paediatrics and Emergency Medicine, University of Western Australia, Crawley, Western Australia, Australia.

Stuart Dalziel (S)

Emergency Department, Starship Children's Health, Auckland, New Zealand.
Departments of Surgery and Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.

James Holmes (J)

Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento, California, USA.
Center for Healthcare Policy and Research, University of California Davis Health System, Sacramento, California, USA.

Nathan Kuppermann (N)

Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento, California, USA.
Department of Pediatrics, University of California Davis School of Medicine, Sacramento, California, USA.

Franz E Babl (FE)

Department of Paediatrics, The University of Melbourne Faculty of Medicine Dentistry and Health Sciences, Melbourne, Victoria, Australia.
Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Emergency Department, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Jeffrey S Hoch (JS)

Center for Healthcare Policy and Research, University of California Davis Health System, Sacramento, California, USA.
Department of Public Health Sciences, University of California Davis, Davis, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH